Extensively Drug‐Resistant Tuberculosis: 2 Years of Surveillance in Iran
Open Access
- 1 October 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 43 (7), 841-847
- https://doi.org/10.1086/507542
Abstract
Background. Extensively drug-resistant (XDR) tuberculosis (TB) is a cause of concern, because it renders patients untreatable with available drugs. In this study, we documented the existence and transmission of XDR TB among patients with multidrug-resistant TB. These patients were referred to the National Research Institute of Tuberculosis and Lung Diseases (Tehran, Iran) for treatment and diagnosis from 2003 to 2005. Methods. The sputum specimens from a total of 2030 patients with TB were digested, examined microscopically for acid-fast bacilli, and inoculated into Löwenstein-Jensen slants by standard procedures. Testing of susceptibility to first-line drugs was performed for 1284 Mycobacterium tuberculosis isolates. Subsequently, the strains that were identified as multidrug-resistant M. tuberculosis (113 isolates) were subjected to susceptibility testing for second-line drugs. Spoligotyping and restriction fragment-length polymorphism were performed for strains that were identified as XDR M. tuberculosis. Results. A total of 12 (10.9%) of 113 multidrug-resistant M. tuberculosis strains were resistant to all 8 second-line drugs tested and, therefore, were denoted as XDR M. tuberculosis. Retrospective analysis of the cases of XDR TB showed that all of them belonged to 1 of 2 epidemiological clusters, either a single-family cluster (4 cases) or a cluster of close contacts (8 cases). The strains were identified as belonging to the M. tuberculosis superfamilies Haarlem 1 and East African Indian 3. Conclusions. The emergence of XDR TB cases in Iran highlights the need to reinforce the Iranian TB policy with regard to control and detection strategies.Keywords
This publication has 17 references indexed in Scilit:
- Treatment of multiple drug-resistant tuberculosis (MDR-TB) in IranInternational Journal of Infectious Diseases, 2005
- Tuberculosis due to Resistant Haarlem Strain, TunisiaEmerging Infectious Diseases, 2005
- Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort studyThe Lancet, 2005
- Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?Journal of Antimicrobial Chemotherapy, 2004
- Multidrug-resistant Tuberculosis in Central AsiaEmerging Infectious Diseases, 2004
- Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, PeruNew England Journal of Medicine, 2003
- Multidrug-Resistant Tuberculosis in Prison Inmates, AzerbaijanEmerging Infectious Diseases, 2001
- [15] DNA Fingerprinting of mycobacterium tuberculosisMethods in Enzymology, 1994